Invention Grant
- Patent Title: Cancer immunotherapy with semi-allogeneic cells
- Patent Title (中): 半同种异体细胞的癌症免疫治疗
-
Application No.: US12115868Application Date: 2008-05-06
-
Publication No.: US07670611B2Publication Date: 2010-03-02
- Inventor: Edward P. Cohen
- Applicant: Edward P. Cohen
- Applicant Address: US IL Urbana
- Assignee: The Board of Trustees of the University of Illinois
- Current Assignee: The Board of Trustees of the University of Illinois
- Current Assignee Address: US IL Urbana
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- Main IPC: A61K35/12
- IPC: A61K35/12 ; C12N15/85
Abstract:
The present invention relates to improved semi-allogeneic immunogenic cells which act to stimulate and induce an immunological response when administered to an individual. In particular, it relates to cells which express both allogeneic and syngeneic MHC determinants and which also express at least one antigen recognized by T lymphocytes. The invention is also directed to methods of inducing an immune response and methods of treating tumors by administering the semi-allogeneic immunogenic cells to an individual.
Public/Granted literature
- US20080305131A1 Cancer Immunotherapy with Semi-Allogeneic Cells Public/Granted day:2008-12-11
Information query
